We are live on
!
Find out more
SC
Searle & Co Portfolio holdings
AUM
$398M
1-Year Est. Return
22.87%
This Fund
S&P 500
This Quarter
Est. Return
+1.89%
1 Year Est. Return
+22.87%
3 Year Est. Return
+66.45%
5 Year Est. Return
+103%
10 Year Est. Return
+295.26%
AUM
$115M
AUM Growth
+$105M
(+1,069%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
92.06%
Top 10 Holdings %
Top 10 Hldgs %
31.17%
Holding
115
New
89
Increased
21
Reduced
–
Closed
1
Top Buys
| 1 |
ExxonMobil
XOM
|
+$5.39M |
| 2 |
Johnson & Johnson
JNJ
|
+$4.38M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$4.25M |
| 4 |
IBM
IBM
|
+$3.33M |
| 5 |
Bank of America
BAC
|
+$3.13M |
Top Sells
| 1 |
DNY
DONNELLEY R R & SONS CO
DNY
|
+$169K |
Sector Composition
| 1 | Healthcare | 24.25% |
| 2 | Energy | 15.24% |
| 3 | Technology | 11.3% |
| 4 | Industrials | 10.25% |
| 5 | Financials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$611B
| $7.35M | 6.39% |
85,257
+60,795
| +249% | +$5.39M |
|
|
2
Johnson & Johnson
JNJ
$609B
| $4.29M | 3.73% |
+36,104
| New | +$4.38M |
|
|
3
Bristol-Myers Squibb
BMY
$124B
| $3.65M | 3.18% |
+66,200
| New | +$4.25M |
|
|
4
IBM
IBM
$200B
| $3.63M | 3.15% |
24,270
+21,948
| +945% | +$3.33M |
|
|
5
Bank of America
BAC
$430B
| $3.32M | 2.88% |
+209,966
| New | +$3.13M |
|
6
Yum! Brands
YUM
$40.8B
| $3.13M | 2.72% |
48,220
+41,034
| +571% | +$2.62M |
|
7
Philip Morris
PM
$301B
| $2.99M | 2.59% |
31,073
+25,941
| +505% | +$2.6M |
|
|
AGN
8
DELISTED
Allergan plc
AGN
| $2.76M | 2.4% |
11,692
+10,292
| +735% | +$2.52M |
|
9
McDonald's
MCD
$190B
| $2.39M | 2.07% |
+21,025
| New | +$2.49M |
|
10
CVS Health
CVS
$137B
| $2.36M | 2.05% |
+27,398
| New | +$2.59M |
|
11
Honeywell
HON
$71.3B
| $2.2M | 1.91% |
+21,324
| New | +$2.23M |
|
12
Apple
AAPL
$4.9T
| $1.95M | 1.7% |
69,048
+40,648
| +143% | +$1.08M |
|
13
Microsoft
MSFT
$2.93T
| $1.93M | 1.68% |
33,706
+28,790
| +586% | +$1.63M |
|
14
Visa
V
$682B
| $1.89M | 1.64% |
22,790
+18,690
| +456% | +$1.5M |
|
|
BPL
15
DELISTED
Buckeye Partners, L.P.
BPL
| $1.8M | 1.57% |
+25,740
| New | +$1.83M |
|
16
Walt Disney
DIS
$170B
| $1.76M | 1.53% |
+19,040
| New | +$1.82M |
|
17
Procter & Gamble
PG
$349B
| $1.63M | 1.42% |
+18,484
| New | +$1.61M |
|
18
Merck
MRK
$315B
| $1.62M | 1.41% |
+27,139
| New | +$1.59M |
|
19
PepsiCo
PEP
$187B
| $1.58M | 1.37% |
+14,762
| New | +$1.59M |
|
20
AT&T
T
$152B
| $1.57M | 1.37% |
+52,211
| New | +$1.65M |
|
21
American Express
AXP
$242B
| $1.56M | 1.35% |
+24,400
| New | +$1.57M |
|
22
Revvity
RVTY
$12.3B
| $1.55M | 1.35% |
27,800
+19,300
| +227% | +$1.05M |
|
|
MMP
23
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $1.54M | 1.34% |
22,130
+13,130
| +146% | +$937K |
|
24
Palo Alto Networks
PANW
$292B
| $1.54M | 1.33% |
+57,600
| New | +$1.31M |
|
25
Stanley Black & Decker
SWK
$14B
| $1.52M | 1.32% |
+12,350
| New | +$1.49M |
|
Similar funds
CF
VC
DL
ECA
BWM
MHC
LSA
THL
Searle & Co's Q3 2016 Portfolio in Review
As of Q3 2016, Searle & Co held 115 positions worth $115M, up 1,069% from $9.84M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Searle & Co deployed $106M of net new capital in Q3 2016, opening 89 new positions and adding to 21 existing holdings. Its largest new stake was Johnson & Johnson: 36,104 shares worth $4.29M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 14% a quarter earlier, followed by Energy and Technology.
On the sell side, the most notable exit was DONNELLEY R R & SONS CO, an estimated $169K sold.
- Searle & Co's largest Q3 2016 buy was Johnson & Johnson: 36,104 shares worth $4.29M.
- Searle & Co added most to ExxonMobil in Q3 2016, an estimated $5.39M increase.
- Searle & Co fully exited DONNELLEY R R & SONS CO in Q3 2016, selling an estimated $169K.
- Searle & Co's ten largest holdings make up 31% of its $115M portfolio in Q3 2016.
- Searle & Co opened 89 new positions and closed 1 in Q3 2016.
- Searle & Co's portfolio value rose 1,069% quarter-over-quarter to $115M.
Based on Searle & Co's 13F filing for Q3 2016, filed 11 Oct 2016.